Publications by authors named "Matthew Bohm"

Claim this Profile
M
Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS).
Andrea S Shin, Yue Xing, Mohammed Rayyan Waseem, Robert Siwiec, Toyia James-Stevenson, Matthew Bohm

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiota-Short Chain Fatty Acid Relationships Underlie Clinical Heterogeneity and Identify Key Microbial Targets in Irritable Bowel Syndrome (IBS).
Andrea Shin, Yue Xing, Mohammed Rayyan Waseem, Robert Siwiec, Toyia James-Stevenson, Matthew Bohm

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.
Hannah W Fiske, Christopher Ward, Samir A Shah, Stefan D Holubar, Badr Al-Bawardy, Matthew Bohm

Crohns Colitis 360· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Presentation of Small Intestinal Bacterial Overgrowth from Aerodigestive Tract Bacteria Versus Colonic-Type Bacteria: A Comparison Study.
Daanish A Siddique, Claire L Jansson-Knodell, Anita Gupta, Gage Howard, Matthew E Bohm

Dig Dis Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of withdrawal time on adenoma detection rate: results from a prospective multicenter trial.
Madhav Desai, Douglas K Rex, Matthew E Bohm, Perica Davitkov, John M DeWitt

Gastrointest Endosc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Amanda M Johnson, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati, Matthew Bohm

Am J Gastroenterol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome.
Mohammed Rayyan Waseem, Andrea Shin, Robert Siwiec, Toyia James-Stevenson, Matthew Bohm

Clin Transl Gastroenterol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Definition Colonoscopy Compared With Cuff- and Cap-Assisted Colonoscopy: Results From a Multicenter, Prospective, Randomized Controlled Trial.
Madhav Desai, Douglas K Rex, Matthew E Bohm, Perica Davitkov, John M DeWitt

Clin Gastroenterol Hepatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.
Gerardo Calderon, Chirag Patel, Michael Camilleri, Toyia James-Stevenson, Matthew Bohm

J Clin Gastroenterol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
Laura E Raffals, Sumona Saha, Meenakshi Bewtra, Cecile Norris, Angela Dobes, Matthew Bohm

Inflamm Bowel Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Dana Lukin, David Faleck, Ronghui Xu, Yiran Zhang, Aaron Weiss, Matthew Bohm

Clin Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
Yao-Wen Cheng, Dana Alhaffar, Srishti Saha, Sahil Khanna, Matthew Bohm

Clin Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
Jessica R Allegretti, Colleen R Kelly, Ari Grinspan, Benjamin H Mullish, Jonathan Hurtado, Matthew Bohm

Inflamm Bowel Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Gastric Emptying Is Not Associated with a Microbiological Diagnosis of Small Intestinal Bacterial Overgrowth.
Gerardo Calderon, Robert M Siwiec, Matthew E Bohm, Thomas V Nowak, John M Wo

Dig Dis Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Parambir S Dulai, Siddharth Singh, Niels Vande Casteele, Joseph Meserve, Adam Winters, Matthew Bohm

Clin Gastroenterol Hepatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
Yao-Wen Cheng, Emmalee Phelps, Sara Nemes, Nicholas Rogers, Sashidhar Sagi, Matthew Bohm

Clin Gastroenterol Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease.
Thomas Strobel, Waseem Ahmed, Carlo De la Sancha, Matthew Bohm, Monika Fischer

ACG Case Rep J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
Matthew Bohm, Ronghui Xu, Yiran Zhang, Sashidhar Varma, Monika Fischer

Aliment Pharmacol Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study.
Andrea S Shin, Xiang Gao, Matthew Bohm, Huaiying Lin, Anita Gupta

Clin Transl Gastroenterol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a ring-fitted cap on insertion time and adenoma detection: a randomized controlled trial.
Douglas K Rex, William R Kessler, Sashidhar V Sagi, Nicholas A Rogers, Monika Fischer, Matthew E Bohm

Gastrointest Endosc· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
David M Faleck, Adam Winters, Shreya Chablaney, Preeti Shashi, Joseph Meserve, Matthew Bohm

Clin Gastroenterol Hepatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of 2 distal attachment mucosal exposure devices: a noninferiority randomized controlled trial.
Douglas K Rex, Sashidhar V Sagi, William R Kessler, Nicholas A Rogers, Monika Fischer, Matthew E Bohm

Gastrointest Endosc· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.
Jenna L Koliani-Pace, Siddharth Singh, Michelle Luo, Robert Hirten, Satimai Aniwan, Matthew Bohm

Inflamm Bowel Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study.
Andrea S Shin, Xiang Gao, Matthew Bohm, Huaiying Lin, Anita Gupta

Clin Transl Gastroenterol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose.
Jessica R Allegretti, Monika Fischer, Sashidhar V Sagi, Matthew E Bohm, Hala M Fadda

Dig Dis Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis